Literature DB >> 33929324

CD8+ T cell self-tolerance permits responsiveness but limits tissue damage.

Emily N Truckenbrod1, Kristina S Burrack1, Todd P Knutson2, Henrique Borges da Silva1, Katharine E Block1, Stephen D O'Flanagan1, Katie R Stagliano1, Arthur A Hurwitz1, Ross B Fulton1, Kristin R Renkema1, Stephen C Jameson1.   

Abstract

Self-specific CD8+T cells can escape clonal deletion, but the properties and capabilities of such cells in a physiological setting are unclear. We characterized polyclonal CD8+ T cells specific for the melanocyte antigen tyrosinase-related protein 2 (Trp2) in mice expressing or lacking this enzyme (due to deficiency in Dct, which encodes Trp2). Phenotypic and gene expression profiles of pre-immune Trp2/Kb-specific cells were similar; the size of this population was only slightly reduced in wild-type (WT) compared to Dct-deficient (Dct-/-) mice. Despite comparable initial responses to Trp2 immunization, WT Trp2/Kb-specific cells showed blunted expansion and less readily differentiated into a CD25+proliferative population. Functional self-tolerance clearly emerged when assessing immunopathology: adoptively transferred WT Trp2/Kb-specific cells mediated vitiligo much less efficiently. Hence, CD8+ T cell self-specificity is poorly predicted by precursor frequency, phenotype, or even initial responsiveness, while deficient activation-induced CD25 expression and other gene expression characteristics may help to identify functionally tolerant cells.

Entities:  

Keywords:  T cell; autoimmune response/disease; immunology; inflammation; mouse; tolerance

Year:  2021        PMID: 33929324     DOI: 10.7554/eLife.65615

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  1 in total

Review 1.  Functional heterogeneity and adaptation of naive T cells in response to tonic TCR signals.

Authors:  Joel Eggert; Byron B Au-Yeung
Journal:  Curr Opin Immunol       Date:  2021-10-12       Impact factor: 7.486

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.